{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:50:20Z","timestamp":1790484620645,"version":"4.1.0"},"reference-count":117,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>As with any other intervention in health, liver transplantation (LT) entails a variety of risks, including donor-transmitted cancers (DTCs). At present, 2%\u20134% of used deceased organ donors are known to have a current or past history of malignancy. The frequency of DTCs is consistently reported at 3\u20136 cases per 10 000 solid organ transplants, with a similar frequency in the LT setting. A majority of DTCs are occult cancers unknown in the donor at the time of transplantation. Most DTCs are diagnosed within 2 y after LT and are associated with a 51% probability of survival at 2 y following diagnosis. The probability of death is greatest for DTCs that have already metastasized at the time of diagnosis. The International Liver Transplantation Society-Sociedad Espa\u00f1ola de Trasplante Hep\u00e1tico working group on DTC has provided guidance on how to minimize the occurrence of DTCs while avoiding the unnecessary loss of livers for transplantation both in deceased and living donor LT. The group endorses the Council of Europe classification of risk of transmission of cancer from donor to recipient (minimal, low to intermediate, high, and unacceptable), classifies a range of malignancies in the liver donor into these 4 categories, and recommends when to consider LT, mindful of the risk of DTCs, and the clinical condition of patients on the waiting list. We further provide recommendations to professionals who identify DTC events, stressing the need to immediately alert all stakeholders concerned, so a coordinated investigation and management can be initiated; decisions on retransplantation should be made on a case-by-case basis with a multidisciplinary approach.<\/jats:p>","DOI":"10.1097\/tp.0000000000003995","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T22:04:50Z","timestamp":1639519490000},"page":"e12-e29","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Prevention and Management of Donor-transmitted Cancer After Liver Transplantation: Guidelines From the ILTS-SETH Consensus Conference"],"prefix":"10.1097","volume":"106","author":[{"given":"Beatriz","family":"Dom\u00ednguez-Gil","sequence":"first","affiliation":[{"name":"Organizaci\u00f3n Nacional de Trasplantes, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Moench","sequence":"additional","affiliation":[{"name":"Donor Transplant Coordination Unit, Westpfalz-Klinikum, Kaiserslautern, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Watson","sequence":"additional","affiliation":[{"name":"The Roy Calne Transplant Unit and Department of Surgery, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Trinidad","family":"Serrano","sequence":"additional","affiliation":[{"name":"Hepatology Section, Hospital Cl\u00ednico Universitario Lozano Blesa, Zaragoza, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taizo","family":"Hibi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery and Transplantation, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Asencio","sequence":"additional","affiliation":[{"name":"Liver Transplant Unit, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Van Rosmalen","sequence":"additional","affiliation":[{"name":"Eurotransplant, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Detry","sequence":"additional","affiliation":[{"name":"Department of Abdominal Surgery and Transplantation, Centre Hospitalier Universitaire de Liege, University of Liege, Liege, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Heimbach","sequence":"additional","affiliation":[{"name":"Liver Transplantation Unit, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Durand","sequence":"additional","affiliation":[{"name":"Hepatology Department, Liver Intensive Care Unit, Hospital Beaujon, Clichy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2004.00703.x","article-title":"The survival benefit of liver transplantation.","volume":"5","author":"Merion","year":"2005","journal-title":"Am J Transplant"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/liv.12553","article-title":"Liver transplantation: a systematic review of long-term quality of life.","volume":"34","author":"Yang","year":"2014","journal-title":"Liver Int"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/TP.0000000000003994","article-title":"The ILTS-SETH Consensus Conference on Extrahepatic Cancer and Liver Transplantation: paving the way.","volume":"106","author":"Colmenero","year":"2022","journal-title":"Transplantation"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1097\/00007890-200212270-00001","article-title":"Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation.","volume":"74","author":"Feng","year":"2002","journal-title":"Transplantation"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1067\/msy.2001.117102","article-title":"Transmission of donor cancer into cardiothoracic transplant recipients.","volume":"130","author":"Buell","year":"2001","journal-title":"Surgery"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01.TP.0000076094.64973.D8","article-title":"Donors with central nervous system malignancies: are they truly safe?","volume":"76","author":"Buell","year":"2003","journal-title":"Transplantation"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.transproceed.2004.12.118","article-title":"Donor kidneys with small renal cell cancers: can they be transplanted?","volume":"37","author":"Buell","year":"2005","journal-title":"Transplant Proc"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0041-1345(98)01989-7","article-title":"Risk of tumor transmission in transplantation from donors with primary brain tumors: an Australian and New Zealand registry report.","volume":"31","author":"Chui","year":"1999","journal-title":"Transplant Proc"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1432-2277.2001.tb00070.x","article-title":"The fate of recipients of organs from donors with diagnosis of primary brain tumor.","volume":"14","author":"Pokorna","year":"2001","journal-title":"Transpl Int"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00007890-200211270-00012","article-title":"Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors.","volume":"74","author":"Birkeland","year":"2002","journal-title":"Transplantation"},{"issue":"suppl 10","key":"R14-20250604","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00007890-201211271-00388","article-title":"6-year survey of organ donors with malignancies in Germany: 1449.","volume":"94","author":"Moench","year":"2012","journal-title":"Transplantation"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/TP.0b013e31816c2d42","article-title":"The Italian multiorgan donor cancer screening protocol: 2002\u20132005 experience.","volume":"85","author":"Zucchini","year":"2008","journal-title":"Transplantation"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s40620-018-00573-z","article-title":"How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network.","volume":"32","author":"Eccher","year":"2019","journal-title":"J Nephrol"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/TP.0000000000002994","article-title":"Safety of donation from brain-dead organ donors with central nervous system tumors: analysis of transplantation outcomes in Korea.","volume":"104","author":"Lee","year":"2020","journal-title":"Transplantation"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/TP.0b013e31816c2f55","article-title":"The Spanish National Transplant Organization (ONT) tumor registry.","volume":"85","author":"Garrido","year":"2008","journal-title":"Transplantation"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1600-6143.2010.03130.x","article-title":"How safe is it to transplant organs from deceased donors with primary intracranial malignancy? An analysis of UK Registry data.","volume":"10","author":"Watson","year":"2010","journal-title":"Am J Transplant"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/TP.0b013e318272df41","article-title":"Cancer transmission from organ donors-unavoidable but low risk.","volume":"94","author":"Desai","year":"2012","journal-title":"Transplantation"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/bjs.9460","article-title":"Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry.","volume":"101","author":"Desai","year":"2014","journal-title":"Br J Surg"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00007890-200012270-00014","article-title":"First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer.","volume":"70","author":"Kauffman","year":"2000","journal-title":"Transplantation"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/S0041-1345(00)02703-2","article-title":"UNOS Transplant Tumor Registry: donors with a history of cancer.","volume":"33","author":"Kauffman","year":"2001","journal-title":"Transplant Proc"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00007890-200208150-00011","article-title":"Transplant tumor registry: donor related malignancies.","volume":"74","author":"Myron Kauffman","year":"2002","journal-title":"Transplantation"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.tp.0000267919.93425.fb","article-title":"Deceased donors with a past history of malignancy: an Organ Procurement and Transplantation Network\/United Network for Organ Sharing update.","volume":"84","author":"Kauffman","year":"2007","journal-title":"Transplantation"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1215\/S1152851703000474","article-title":"Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature.","volume":"6","author":"Armanios","year":"2004","journal-title":"Neuro Oncol"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00007890-200202270-00017","article-title":"Transplant tumor registry: donors with central nervous system tumors.","volume":"73","author":"Kauffman","year":"2002","journal-title":"Transplantation"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"e12919","DOI":"10.1111\/ctr.12919","article-title":"Risk of tumor transmission after thoracic allograft transplantation from adult donors with central nervous system neoplasm\u2014a UNOS database study.","volume":"31","author":"Hynes","year":"2017","journal-title":"Clin Transplant"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/ajt.16178","article-title":"Ten years of donor-derived disease: a report of the disease transmission advisory committee.","volume":"21","author":"Kaul","year":"2021","journal-title":"Am J Transplant"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/lt.25858","article-title":"Donor-transmitted cancers in transplanted livers: analysis of clinical outcomes.","volume":"27","author":"Eccher","year":"2021","journal-title":"Liver Transpl"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jhep.2006.07.019","article-title":"How can donors with a previous malignancy be evaluated?","volume":"45","author":"Buell","year":"2006","journal-title":"J Hepatol"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.transproceed.2020.10.034","article-title":"Donor choriocarcinoma transmission from solid organ transplantation: a case report.","volume":"53","author":"de Queiroz Moura","year":"2021","journal-title":"Transplant Proc"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1097\/TXD.0000000000000953","article-title":"Whole body CT imaging in deceased donor screening for malignancies.","volume":"5","author":"Mensink","year":"2019","journal-title":"Transplant Direct"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"e13045","DOI":"10.1111\/ctr.13045","article-title":"Rapid screening for malignancy in organ donors: 15-year experience with the Verona \u201cAlert\u201d protocol and review of the literature.","volume":"31","author":"Eccher","year":"2017","journal-title":"Clin Transplant"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1600-6143.2011.03565.x","article-title":"Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.","volume":"11","author":"Nalesnik","year":"2011","journal-title":"Am J Transplant"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/hep.29907","article-title":"Reframing the approach to patients with hepatocellular carcinoma: longitudinal assessment with hazard associated with liver transplantation for HCC (HALTHCC) improves ablate and wait strategy.","volume":"68","author":"Firl","year":"2018","journal-title":"Hepatology"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/lt.25333","article-title":"The mRECIST classification provides insight into tumor biology for patients with hepatocellular carcinoma awaiting liver transplantation.","volume":"25","author":"Lee","year":"2019","journal-title":"Liver Transpl"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers.","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/ajt.14660","article-title":"MELD as a metric for survival benefit of liver transplantation.","volume":"18","author":"Luo","year":"2018","journal-title":"Am J Transplant"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jhep.2008.09.012","article-title":"Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience.","volume":"50","author":"Bernal","year":"2009","journal-title":"J Hepatol"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.gastro.2018.12.007","article-title":"Factors associated with survival of patients with severe acute-on-chronic liver failure before and after liver transplantation.","volume":"156","author":"Sundaram","year":"2019","journal-title":"Gastroenterology"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1432-2277.2009.00920.x","article-title":"Living donor liver transplantation using a left hepatic graft from a donor with a history of gastric cancer operation.","volume":"23","author":"Uchiyama","year":"2010","journal-title":"Transpl Int"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1600-6143.2005.00740.x","article-title":"Liver transplantation from a living donor with early gastric cancer.","volume":"5","author":"Fujiwara","year":"2005","journal-title":"Am J Transplant"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1111\/j.1600-6143.2005.00981.x","article-title":"Transplantation of a liver graft from a living donor with early gastric cancer.","volume":"5","author":"Detry","year":"2005","journal-title":"Am J Transplant"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001770","article-title":"KDIGO clinical practice guideline on the evaluation and care of living kidney donors.","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM200105243442112","article-title":"Transplantation of liver grafts from living donors into adults\u2014too much, too soon.","volume":"344","author":"Cronin","year":"2001","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"R50-20250604","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1002\/lt.22356","article-title":"Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations.","volume":"17","author":"Pomfret","year":"2011","journal-title":"Liver Transpl"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","article-title":"Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.","volume":"25","author":"Hashiguchi","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-016-0622-4","article-title":"Japanese gastric cancer treatment guidelines 2014 (ver. 4).","volume":"20","year":"2017","journal-title":"Gastric Cancer"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1046\/j.1600-6143.2003.00245.x","article-title":"Tumors and transplantation: the 2003 Third Annual ASTS State-of-the-Art Winter Symposium.","volume":"3","author":"Feng","year":"2003","journal-title":"Am J Transplant"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/ajt.14766","article-title":"Transmission of breast cancer by a single multiorgan donor to 4 transplant recipients.","volume":"18","author":"Matser","year":"2018","journal-title":"Am J Transplant"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ijrobp.2009.12.011","article-title":"Estrogen\/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer.","volume":"77","author":"Albert","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1158\/0008-5472.CAN-06-3316","article-title":"Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.","volume":"67","author":"Palmieri","year":"2007","journal-title":"Cancer Res"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"29765","DOI":"10.1038\/srep29765","article-title":"Patterns of metastasis in colon and rectal cancer.","volume":"6","author":"Riihim\u00e4ki","year":"2016","journal-title":"Sci Rep"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1097\/TXD.0000000000000738","article-title":"Liver transplantation from donors with a history of malignancy: a single-center experience.","volume":"3","author":"Benk\u00f6","year":"2017","journal-title":"Transplant Direct"},{"key":"R61-20250604","first-page":"56","article-title":"A liver nodule in a patient transplanted for primary sclerosing cholangitis: an interdisciplinary diagnostic approach.","volume":"55","author":"Loosen","year":"2017","journal-title":"Z Gastroenterol"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/lt.21347","article-title":"Donor-transmitted malignancy confirmed by quantitative fluorescence polymerase chain reaction genotype analysis: a rare indication for liver retransplantation.","volume":"14","author":"Snape","year":"2008","journal-title":"Liver Transpl"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1111\/j.1432-2277.2011.01380.x","article-title":"Donor-transmitted metastasis of colorectal carcinoma in a transplanted liver.","volume":"25","author":"Zelinkova","year":"2012","journal-title":"Transpl Int"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s10620-012-2501-0","article-title":"Donor-transmitted malignancy in a liver transplant recipient: a case report and review of literature.","volume":"58","author":"Kim","year":"2013","journal-title":"Dig Dis Sci"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.trre.2004.09.003","article-title":"Donor transmission of primary brain tumors:a neurooncologic perspective.","volume":"18","author":"Cavaliere","year":"2004","journal-title":"Transplant Rev (Philadelphia)"},{"key":"R66-20250604","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1586\/14737140.2015.1028374","article-title":"Extra-CNS metastasis from glioblastoma: a rare clinical entity.","volume":"15","author":"Awan","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1097\/01.TP.0000132350.96061.73","article-title":"Which donors with brain tumors are safe?","volume":"77","author":"Schiff","year":"2004","journal-title":"Transplantation"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/lt.21838","article-title":"Liver grafts from donors with central nervous system tumors: a single-center perspective.","volume":"15","author":"Kashyap","year":"2009","journal-title":"Liver Transpl"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/lt.22057","article-title":"Reply: Liver grafts from donors with central nervous system tumors: a single-center perspective.","volume":"16","author":"Schiff","year":"2010","journal-title":"Liver Transpl"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2008.16.3543","article-title":"Transmission of glioblastoma multiforme after bilateral lung transplantation.","volume":"26","author":"Chen","year":"2008","journal-title":"J Clin Oncol"},{"key":"R71-20250604","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/00007890-199403270-00034","article-title":"Transmission of CNS malignancy by organ transplantation.","volume":"57","author":"Colquhoun","year":"1994","journal-title":"Transplantation"},{"key":"R72-20250604","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/RCT.0b013e318076b472","article-title":"Transmission of metastatic glioblastoma multiforme from donor to lung transplant recipient.","volume":"32","author":"Fatt","year":"2008","journal-title":"J Comput Assist Tomogr"},{"key":"R73-20250604","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00007890-199011000-00026","article-title":"Development of a malignant tumor in a liver transplant graft procured from a donor with a cerebral neoplasm.","volume":"50","author":"Morse","year":"1990","journal-title":"Transplantation"},{"key":"R74-20250604","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1432-2277.1996.tb00903.x","article-title":"Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia.","volume":"9","author":"Jonas","year":"1996","journal-title":"Transpl Int"},{"key":"R75-20250604","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(98)24027-X","article-title":"Transmission of glioblastoma multiforme through liver transplantation.","volume":"352","author":"Frank","year":"1998","journal-title":"Lancet"},{"key":"R77-20250604","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/TP.0b013e31823f7f47","article-title":"Advising potential recipients on the use of organs from donors with primary central nervous system tumors.","volume":"93","author":"Warrens","year":"2012","journal-title":"Transplantation"},{"key":"R78-20250604","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.transproceed.2004.12.125","article-title":"Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality.","volume":"37","author":"Buell","year":"2005","journal-title":"Transplant Proc"},{"key":"R80-20250604","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","article-title":"Metastatic sites and survival in lung cancer.","volume":"86","author":"Riihim\u00e4ki","year":"2014","journal-title":"Lung Cancer"},{"key":"R81-20250604","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1634\/theoncologist.2018-0517","article-title":"A case of donor-transmitted non-small cell lung cancer after liver transplantation: an unwelcome guest.","volume":"24","author":"Sonbol","year":"2019","journal-title":"Oncologist"},{"key":"R82-20250604","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/jlts.2003.50174","article-title":"Death from donor-transmitted malignancy despite emergency liver retransplantation.","volume":"9","author":"Lipshutz","year":"2003","journal-title":"Liver Transpl"},{"key":"R83-20250604","first-page":"14","article-title":"Evaluation of transplant candidates with pre-existing malignancies.","volume":"2","author":"Penn","year":"1997","journal-title":"Ann Transplant"},{"key":"R84-20250604","first-page":"109","article-title":"Evaluation of the candidate with a previous malignancy.","volume":"2","author":"Penn","year":"1996","journal-title":"Liver Transpl Surg"},{"key":"R86-20250604","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-6143.2011.03493.x","article-title":"An update on donor-derived disease transmission in organ transplantation.","volume":"11","author":"Ison","year":"2011","journal-title":"Am J Transplant"},{"key":"R88-20250604","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1200\/JCO.2015.65.7270","article-title":"Meta-analysis evaluating the impact of site of metastasis on overall survival in men with castration-resistant prostate cancer.","volume":"34","author":"Halabi","year":"2016","journal-title":"J Clin Oncol"},{"key":"R89-20250604","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.transproceed.2016.01.092","article-title":"Prostate-specific antigen: nonspecific in deceased organ donors.","volume":"48","author":"Pabisiak","year":"2016","journal-title":"Transplant Proc"},{"key":"R90-20250604","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.transproceed.2015.12.142","article-title":"Prostate specific antigen-positive deceased organ donor: a pathologist is indispensable.","volume":"48","author":"Pabisiak","year":"2016","journal-title":"Transplant Proc"},{"key":"R91-20250604","doi-asserted-by":"crossref","first-page":"378","DOI":"10.14309\/ajg.0000000000000135","article-title":"Periesophageal lymph node metastasis of prostate adenocarcinoma from liver transplant donor.","volume":"114","author":"S\u00e1nchez-Montes","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R92-20250604","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/jama.1997.03540260047034","article-title":"Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation.","volume":"277","author":"Loh","year":"1997","journal-title":"JAMA"},{"key":"R93-20250604","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.juro.2007.10.057","article-title":"Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors.","volume":"179","author":"Yin","year":"2008","journal-title":"J Urol"},{"key":"R94-20250604","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.transproceed.2012.06.030","article-title":"The use of neoplastic donors to increase the donor pool.","volume":"44","author":"Fiaschetti","year":"2012","journal-title":"Transplant Proc"},{"key":"R95-20250604","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.lts.2003.09.024","article-title":"If the donor had an early-stage genitourinary carcinoma and the liver has already been implanted, should we perform the transplantectomy?","volume":"9","author":"Serralta","year":"2003","journal-title":"Liver Transpl"},{"key":"R96-20250604","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.transproceed.2018.02.129","article-title":"Prostate cancer in deceased organ donors: loss of organ or transplantation with active surveillance.","volume":"50","author":"Skalski","year":"2018","journal-title":"Transplant Proc"},{"key":"R97-20250604","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/tri.12962","article-title":"Use of donors with genitourinary malignancies for liver transplantation: a calculated risk?","volume":"30","author":"Pezzati","year":"2017","journal-title":"Transpl Int"},{"key":"R98-20250604","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/ajt.12683","article-title":"Cancers among US organ donors: a comparison of transplant and cancer registry diagnoses.","volume":"14","author":"Engels","year":"2014","journal-title":"Am J Transplant"},{"key":"R99-20250604","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/j.1600-6143.2010.03198.x","article-title":"Expanding the criteria of organ procurement from donors with prostate cancer: the application of the new Italian guidelines.","volume":"10","author":"D\u2019Errico-Grigioni","year":"2010","journal-title":"Am J Transplant"},{"key":"R100-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trre.2013.10.003","article-title":"Prostate cancer in deceased organ donors: a review.","volume":"28","author":"Doerfler","year":"2014","journal-title":"Transplant Rev"},{"key":"R101-20250604","doi-asserted-by":"crossref","first-page":"e13597","DOI":"10.1111\/ctr.13597","article-title":"Renal cell carcinoma suspected at time of organ donation 2008\u20132016: a report of the OPTN ad hoc Disease Transmission Advisory Committee Registry.","volume":"33","author":"Pavlakis","year":"2019","journal-title":"Clin Transplant"},{"key":"R102-20250604","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/00007890-199906150-00008","article-title":"The incidence and implications of renal cell carcinoma in cadaveric renal transplants at the time of organ recovery.","volume":"67","author":"Carver","year":"1999","journal-title":"Transplantation"},{"key":"R103-20250604","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","article-title":"European Association of Urology Guidelines on Renal Cell Carcinoma: the 2019 update.","volume":"75","author":"Ljungberg","year":"2019","journal-title":"Eur Urol"},{"key":"R104-20250604","doi-asserted-by":"crossref","first-page":"661.e7","DOI":"10.1016\/j.urolonc.2017.06.060","article-title":"Metastatic renal cell carcinoma: patterns and predictors of metastases\u2014a contemporary population-based series.","volume":"35","author":"Chandrasekar","year":"2017","journal-title":"Urol Oncol"},{"key":"R105-20250604","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00007890-200108150-00034","article-title":"Fate of a renal tubulopapillary adenoma transmitted by an organ donor.","volume":"72","author":"Barrou","year":"2001","journal-title":"Transplantation"},{"key":"R106-20250604","first-page":"298","article-title":"Transferral of extrathoracic donor neoplasm by the cardiac allograft.","volume":"16","author":"Sack","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"R107-20250604","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF00869005","article-title":"Cerebral metastases of an allogenic renal cell carcinoma in a heart recipient without renal cell carcinoma.","volume":"243","author":"Meyding-Lamad\u00e9","year":"1996","journal-title":"J Neurol"},{"key":"R108-20250604","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.tp.0000247794.50318.4a","article-title":"A population-based study of cancer incidence in solid organ transplants from donors at various risk of neoplasia.","volume":"83","author":"Taioli","year":"2007","journal-title":"Transplantation"},{"key":"R109-20250604","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.transproceed.2007.05.069","article-title":"Incidence of neoplastic donors in Organizzazione Centro Sud Trapianti area during the 2003\u20132005 period.","volume":"39","author":"Pretagostini","year":"2007","journal-title":"Transplant Proc"},{"key":"R110-20250604","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/tri.12693","article-title":"Transplantation of liver and kidney from donors with malignancy at the time of donation: an experience from a single centre.","volume":"29","author":"Pandanaboyana","year":"2016","journal-title":"Transpl Int"},{"key":"R113-20250604","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1007\/s00268-018-4609-7","article-title":"Re-transplantation for hepatic artery thrombosis: a national perspective.","volume":"42","author":"Lui","year":"2018","journal-title":"World J Surg"},{"key":"R114-20250604","doi-asserted-by":"crossref","first-page":"e46643","DOI":"10.1371\/journal.pone.0046643","article-title":"Liver retransplantation in adults: the largest multicenter Italian study.","volume":"7","author":"Maggi","year":"2012","journal-title":"PLoS One"},{"key":"R115-20250604","first-page":"1230","article-title":"Liver re-transplantation: internal validation of a predictive mathematical model of survival.","volume":"59","author":"Mattos","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"R116-20250604","first-page":"779","article-title":"De novo primary liver cancer after liver transplantation: a French National Study on 15803 patients.","volume":"16","author":"Allaire","year":"2018","journal-title":"Exp Clin Transplant"},{"key":"R117-20250604","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJMe058018","article-title":"Immunosuppressive drugs and the risk of cancer after organ transplantation.","volume":"352","author":"Dantal","year":"2005","journal-title":"N Engl J Med"},{"key":"R118-20250604","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/ajt.14238","article-title":"Chemotherapy and transplantation: the role of immunosuppression in malignancy and a review of antineoplastic agents in solid organ transplant recipients.","volume":"17","author":"Krisl","year":"2017","journal-title":"Am J Transplant"},{"key":"R119-20250604","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/ajt.15205","article-title":"Outcomes of immunosuppression minimization and withdrawal early after liver transplantation.","volume":"19","author":"Shaked","year":"2019","journal-title":"Am J Transplant"},{"key":"R120-20250604","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet"},{"key":"R121-20250604","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/j.1600-6143.2005.01125.x","article-title":"Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil.","volume":"5","author":"Robson","year":"2005","journal-title":"Am J Transplant"},{"key":"R122-20250604","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/ajt.13596","article-title":"Immunosuppressive medications and squamous cell skin carcinoma: nested case-control study within the Skin Cancer after Organ Transplant (SCOT) cohort.","volume":"16","author":"Coghill","year":"2016","journal-title":"Am J Transplant"},{"key":"R123-20250604","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3109\/10428194.2011.557453","article-title":"Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update.","volume":"52","author":"Dierickx","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"R124-20250604","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000001447","article-title":"Cancer and mTOR inhibitors in transplant recipients.","volume":"101","author":"de Fijter","year":"2017","journal-title":"Transplantation"},{"key":"R125-20250604","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/TP.0000000000000555","article-title":"Three-year outcomes in de novo liver transplant patients receiving everolimus with reduced tacrolimus: follow-up results from a randomized, multicenter study.","volume":"99","author":"Fischer","year":"2015","journal-title":"Transplantation"},{"key":"R126-20250604","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/ajt.14212","article-title":"Efficacy and safety of everolimus and mycophenolic acid with early tacrolimus withdrawal after liver transplantation: a multicenter randomized trial.","volume":"17","author":"Saliba","year":"2017","journal-title":"Am J Transplant"},{"key":"R127-20250604","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/lt.25664","article-title":"Early switch from tacrolimus to everolimus after liver transplantation: outcomes at 2 years.","volume":"25","author":"Saliba","year":"2019","journal-title":"Liver Transpl"},{"key":"R128-20250604","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/lt.25400","article-title":"Very early introduction of everolimus in de novo liver transplantation: results of a multicenter, prospective, randomized trial.","volume":"25","author":"Cillo","year":"2019","journal-title":"Liver Transpl"},{"key":"R129-20250604","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/ajt.12543","article-title":"De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000\u20132003 phase II prospective randomized trial.","volume":"14","author":"Asrani","year":"2014","journal-title":"Am J Transplant"},{"key":"R130-20250604","first-page":"53","article-title":"Donor transmitted malignancies.","volume":"9","author":"Buell","year":"2004","journal-title":"Ann Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:24:06Z","timestamp":1749065046000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":117,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003995","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,13]]}}}